Mwandishi:
Dkt. Mercy M, CO
Mhariri:
Dkt. Benjamin L, MD
Carbamazepine ni moja kati ya dawa inayotumika kuzuia na kupunguza degedege na pia hutumika katika matibabu ya magonjwa ya kiakili.
Majina ya kibishara
Majina mengine ya kibiashara ya Carbamazepine ni;
Tegretol
Equetrol
Epitol
Tegretol XR
Carbamazepine chewtabs
Carbamazepine CR
Carbatrol
Teril
Carnexiv
Carbamazepine ipo kundi gani la dawa?
Carbamazepine ni dawa iliyo katika makundi yafuatayo;
Anticonvulsant
Antimanic
Dawa za Bipola
Dawa zilizo kundi moja na Carbamazepine
Dawa zilizo kundi moja na Carbamazepine ni ;
Brivaracetam
Cannabidiol
Diazepam
Lorazepam
Eslicarbazepine
Ethosuximide
Perampanel
Phenytoin
Tiagabine
Felbamate
Fenfluramine
Lacosamide
Phenobarbital
Lamotrigine
Levetiracetam
Oxcarbazepine
Pregabalin
Zonisamide
Fomu ya dawa ya Carbamazepine
Dawa hii ipo katika fomu ya;
Kidonge
Tembe
Suspesheni kwaajiri ya kunywa
Sindano
Uzito wa dawa ya Carbamazepine
Carbamazepine ina uzito ufuatao;
Vidonge (Epitol)
100mg
Vidonge (Tegretol)
200mg
Vidonge (Tegretol XR)
100mg
200mg
400mg
Tembe (Equetro, Carbatrol)
100mg
200mg
300mg
Suspesheni kwaajiri ya kunywa
100mg/5ml
Sindano
10mg/ml (200mg/20ml Dozi moja kwa vial)
Carbamazepine hutibu nini?
Hutumika kutibu ugonjwa wa kifafa
Hutumika kutibu Trigeminal neuralgia
Hutumika kutibu Bipolar Mania
Namna Carbamazepine inavyoweza kufanya kazi
Carbamazepine inapoingia kwenye kazi hufanya kazi ya kuzuia sodium channel firing na kutibu degedege.
Ufyozwaji wa dawa
Ufyozwaji wa dawa hii hufanyika kwenye mfumo wa chakula mtu akiwa amepata chakula, kiwango cha dawa kinachoonekana kwenye damu ni hadi 85% baada ya mtu kumeza na huchukua masaa 4-5 kwa dawa kuanza kuonekana kwenye damu baada ya mtu kumeza.
Mwingiliano wa Carbamazepine na chakula
Dawa hii ni nzuri ikitumika pamoja na chakula kwani chakula husaidia katika ufyozwaji wa dawa.
Wagonjwa wasiopaswa kutumia Carbamazepine
Wagonjwa wenye mzio wa Carbamazepine.
Wagonjwa wenye bone marrow suppression.
Utoaji taka wa Carbamazepine mwilini
Asilimia sabini na mbili (72%) ya Dawa hii hutolewa njee kwa njia ya mkojo na asilimia ishirini na nane (28%) hutolewa kwa njia ya haja kubwa.
Matumizi ya Carbamazepine kwa mama mjamzito
Tafiti zinaonesha kuwa dawa hii inaweza kuleta madhara kwa mtoto hivyo tahadhari inatakiwa wakati mama anatumia dawa hii.
Matumizi ya Carbamazepine kwa mama anayenyonyesha
Tafiti zinaonesha kuwa dawa hii inatolewa kwenye maziwa ya mama lakini haijaonesha madhara kwa mtoto hivyo kimoja wapo kinatakiwa kizingatiwe kati ya mama kutumia dawa au mtoto kunyonya.
Dawa zenye muingiliano na Carbamazepine
Dawa zenye mwingiliano mkali na hivyo kutofaa kutumika pamoja na Carbamazepine;
Abametapir
Abemaciclib
Amiodarone
Atorvastatin
Avapritinib
Dexamethasone
Diazepam
Erythromycin base
Esomeprazole
Haloperidol
Hydrocortisone
Isosorbide dinitrate
Isosorbide mononitrate
Ketoconazole
Losartan
Methadone
Omeprazole
Prednisolone
Rifampin
Warfarin
Dawa zinazoweza kutumika na Carbamazepine chini ya uangalizi;
Amitriptyline
Amlodipine
Artemether/lumefantrine
Artesunate
Atazanavir
Bosentan
Carvedilol
Clomipramine
Cortisone
Cyclosporine
Dapsone
Diazepame
Doxycycline
Efavirenz
Esomeprazole
Fluconazole
Griseofulvin
Haloperidol
Heparin
Hydrocortisone
Ibuprofen
Isoniazid
Ketamine
Lansoprazole
Lidocaine
Losartan
Lumefantrine
Metronidazole
Mifepristone
Omeprazole
Phenobarbital
Phenytoin
Quinine
Ritonavir
Tamoxifen
Testosterone
Tinidazole
Verapamil
Warfarin
Zonisamide
Dawa zenye mwingiliano mdogo na Carbamazepine
Acetaminophen
Ambrisentan
Amitriptyline
Bupropion
Clomipramine
Dexmethylphenidate
Diclofenac
Dosulepin
Flurbiprofen
Fluvastatin
Folic acid
Fosphenytoin
Frovatriptan
Green tea
Ibuprofen
Ibuprofen iv
Imipramine
Isotretinoin
L-methylfolate
Levocarnitine
Levothyroxine
Liothyronine
Lofepramine
Maprotiline
Mebendazole
Meloxicam
Niacin
Nortriptyline
Omeprazole
Onabotulinumtoxina
Oxcarbazepine
Pancuronium
Perampanel
Phenytoin
Piroxicam
Protriptyline
Sulfamethoxazole
Trazodone
Trimipramine
Vasopressin
Maudhi madogo ya Carbamazepine
Ataxia
Mwili kuchoka
Kusinzia
kutapika
Kukosa hamu ya kula
Kizunguzungu
Maumivu ya kichwa
Mdomo kukauka
Steven Johnson syndrome
Kichefuchefu
Ufanye nini endapo utasahau kutumia dozi yako?
Kama umesahau kutumia dozi yako tumia mara pale utakapokumbuka, kama muda wa dozi inayofata umekaribia usimeze dozi uliyosahau endelea na dozi inayofuata kwa muda uliopangiwa na daktari. Usimeze dozi mbili kufidia uliyosahau.
13 Juni 2023, 19:18:46
Dawa Carbamazepine
Imeboreshwa,
30 Oktoba 2021, 18:39:49
Dawa yoyote ni sumu, usitumie dawa pasipo ushauri wa daktari kuepuka madhara kwenye ogani mbalimbali kama figo na ini. Matumizi ya dawa pasipo ushauri wa daktari unaweza kusababisha madhara na usugu wa vimelea vya maradhi kwenye dawa.
​
ULY CLINIC inakushauri siku zote uwasiliane na daktari wako kwa ushauri na tiba kabla ya kuchukua hatua yoyote ile baad aya kusoma makala hii.
Kupata ushauri zaidi na tiba kutoka kwa daktari wa ULY CLINIC bofya Mawasiliano yetu au Pata tiba.
Rejea za mada hii:
Bäck SE, et al. Age dependence of renal function: clearance of iohexol and p-amino hippurate in healthy males. Scand J Clin Lab Invest. 1989 Nov;49(7):641–646.
Bax RP, et al. The pharmacokinetics of meropenem in volunteers. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):311–320.
Burman LA, et al. Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem. J Antimicrob Chemother. 1991 Feb;27(2):219–224.
Christensson BA, et al. Pharmacokinetics of meropenem in subjects with various degrees of renal impairment. Antimicrob Agents Chemother. 1992 Jul;36(7):1532–1537.
DAVIES DF, SHOCK NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest. 1950 May;29(5):496–507.
Douglas JG, et al. The pharmacokinetics of cefuroxime in the elderly. J Antimicrob Chemother. 1980 Jul;6(4):543–549.
Granerus G, et al. Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. Scand J Clin Lab Invest. 1981 Oct;41(6):611–616.
Harrison MP, et al. The disposition and metabolism of meropenem in laboratory animals and man. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):265–277.
Jones RN, et al. In-vitro studies of meropenem. J Antimicrob Chemother. 1989 Sep;24 (Suppl A):9–29.
Krutzén E, et al. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med. 1984 Dec;104(6):955–961.
Ljungberg B, et al. Pharmacokinetics of antimicrobial agents in the elderly. Rev Infect Dis. 1987 Mar-Apr;9(2):250–264.